These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15258401)

  • 61. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
    Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
    Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A folding inhibitor of the HIV-1 protease.
    Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G
    Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chipping at large, potent human T-cell leukemia virus type 1 protease inhibitors to uncover smaller, equipotent inhibitors.
    Kimura T; Nguyen JT; Maegawa H; Nishiyama K; Arii Y; Matsui Y; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3276-80. PubMed ID: 17448657
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New water-soluble prodrugs of HIV protease inhibitors based on O-->N intramolecular acyl migration.
    Hamada Y; Ohtake J; Sohma Y; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem; 2002 Dec; 10(12):4155-67. PubMed ID: 12413869
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stearic acid solubility and cubic phase volume.
    Schmidt WF; Barone JR; Francis B; Reeves JB
    Chem Phys Lipids; 2006 Jul; 142(1-2):23-32. PubMed ID: 16616908
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism.
    Santos-Filho OA; Hopfinger AJ
    J Chem Inf Model; 2006; 46(1):345-54. PubMed ID: 16426069
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611.
    Engstrom K; Henry R; Hollis LS; Kotecki B; Marsden I; Pu YM; Wagaw S; Wang W
    J Org Chem; 2006 Jul; 71(14):5369-72. PubMed ID: 16808529
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Two-carbon-elongated HIV-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic.
    Wu X; Ohrngren P; Ekegren JK; Unge J; Unge T; Wallberg H; Samuelsson B; Hallberg A; Larhed M
    J Med Chem; 2008 Feb; 51(4):1053-7. PubMed ID: 18215014
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure-guided design of C2-symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffold.
    Blum A; Böttcher J; Heine A; Klebe G; Diederich WE
    J Med Chem; 2008 Apr; 51(7):2078-87. PubMed ID: 18348517
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.
    Lepsík M; Kríz Z; Havlas Z
    Proteins; 2004 Nov; 57(2):279-93. PubMed ID: 15340915
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
    Hidaka K; Kimura T; Tsuchiya Y; Kamiya M; Ruben AJ; Freire E; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3048-52. PubMed ID: 17400453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparing the conformational behavior of a series of diastereomeric cyclic urea HIV-1 inhibitors using the low mode:monte carlo conformational search method.
    Parish CA; Yarger M; Sinclair K; Dure M; Goldberg A
    J Med Chem; 2004 Sep; 47(20):4838-50. PubMed ID: 15369387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
    J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy.
    Blackburn ME; Veloro AM; Fanucci GE
    Biochemistry; 2009 Sep; 48(37):8765-7. PubMed ID: 19691291
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rigid dipeptide mimics: synthesis of enantiopure C6-functionalized pyrrolizidinone amino acids.
    Rao MH; Pinyol E; Lubell WD
    J Org Chem; 2007 Feb; 72(3):736-43. PubMed ID: 17253788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors.
    Wittayanarakul K; Hannongbua S; Feig M
    J Comput Chem; 2008 Apr; 29(5):673-85. PubMed ID: 17849388
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diproline templates as folding nuclei in designed peptides. Conformational analysis of synthetic peptide helices containing amino terminal Pro-Pro segments.
    Rai R; Aravinda S; Kanagarajadurai K; Raghothama S; Shamala N; Balaram P
    J Am Chem Soc; 2006 Jun; 128(24):7916-28. PubMed ID: 16771506
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold.
    Ekegren JK; Unge T; Safa MZ; Wallberg H; Samuelsson B; Hallberg A
    J Med Chem; 2005 Dec; 48(25):8098-102. PubMed ID: 16335934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stability of nucleic acid base pairs in organic solvents: molecular dynamics, molecular dynamics/quenching, and correlated ab initio study.
    Zendlová L; Hobza P; Kabelác M
    J Phys Chem B; 2007 Mar; 111(10):2591-609. PubMed ID: 17302446
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold.
    Ekegren JK; Gising J; Wallberg H; Larhed M; Samuelsson B; Hallberg A
    Org Biomol Chem; 2006 Aug; 4(16):3040-3. PubMed ID: 16886068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.